PRESS RELEASE published on 05/30/2023 at 22:30, 1 year 5 months ago Moolec Science Presents Third Quarter FY 2023 Business Update
PRESS RELEASE published on 05/24/2023 at 22:00, 1 year 5 months ago Moolec Science to Host Third Quarter FY 2023 Business Update Call
PRESS RELEASE published on 04/18/2023 at 04:55, 1 year 7 months ago Moolec Science Secures Up to $50 Million in Committed Equity Financing With Nomura
PRESS RELEASE published on 04/11/2023 at 14:25, 1 year 7 months ago Moolec Science Acquires Food Ingredient Capabilities to Consolidate Molecular Farming Technology
PRESS RELEASE published on 04/05/2023 at 12:00, 1 year 7 months ago Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product
Published on 11/21/2024 at 14:15, 17 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 32 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 32 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 32 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 15 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 17 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 56 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 34 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 12 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
